Your browser doesn't support javascript.
loading
Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience.
Hall, Benjamin James; Bhojwani, Ajay Ashok; Wong, Helen; Law, Andrea; Flint, Helen; Ahmed, Eliyaz; Innes, Helen; Cliff, Joanne; Malik, Zaf; O'Hagan, Julie Elizabeth; Hall, Allison; Sripadam, Rajaram; Tolan, Shaun; Ali, Zulfiqar; Hart, Clare; Errington, Douglas; Alam, Farida; Giuliani, Rosa; Mehta, Shaveta; Khanduri, Sheena; Thorp, Nicky; Jackson, Richard; Cicconi, Silvia; Palmieri, Carlo.
Afiliação
  • Hall BJ; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.
  • Bhojwani AA; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.
  • Wong H; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Law A; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Flint H; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Ahmed E; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Innes H; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Cliff J; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Malik Z; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • O'Hagan JE; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Hall A; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Sripadam R; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Tolan S; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Ali Z; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Hart C; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Errington D; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Alam F; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Giuliani R; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Mehta S; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Khanduri S; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Thorp N; The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool L7 8YA, UK.
  • Jackson R; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool L69 3BX, UK.
  • Cicconi S; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool L69 3BX, UK.
  • Palmieri C; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, Liverpool L69 3GE, UK.
Breast J ; 2022: 7146172, 2022.
Article em En | MEDLINE | ID: mdl-35833190
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article